These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29867953)

  • 1. Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.
    Michielsen LA; van Zuilen AD; Kardol-Hoefnagel T; Verhaar MC; Otten HG
    Front Immunol; 2018; 9():972. PubMed ID: 29867953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Promoter Polymorphism in the CD59 Complement Regulatory Protein Gene in Donor Lungs Correlates With a Higher Risk for Chronic Rejection After Lung Transplantation.
    Budding K; van de Graaf EA; Kardol-Hoefnagel T; Broen JC; Kwakkel-van Erp JM; Oudijk EJ; van Kessel DA; Hack CE; Otten HG
    Am J Transplant; 2016 Mar; 16(3):987-98. PubMed ID: 26517734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Promoter Polymorphism in the CD46 Complement Regulatory Protein Gene Is Associated With Acute Renal Allograft Rejection.
    Park MS; Kim SK; Lee TW; Lee SH; Moon JY; Ihm CG; Kim YH; Kang SW; Jeong KH; Chung JH
    Transplant Proc; 2016 Apr; 48(3):809-12. PubMed ID: 27234742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
    Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
    Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course.
    Bos JW; Groen EJN; Otten HG; Budding K; van Eijk RPA; Curial C; Kardol-Hoefnagel T; Goedee HS; van den Berg LH; van der Pol WL
    J Peripher Nerv Syst; 2024 Jun; 29(2):193-201. PubMed ID: 38528725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
    Bellone S; Roque D; Cocco E; Gasparrini S; Bortolomai I; Buza N; Abu-Khalaf M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Br J Cancer; 2012 Apr; 106(9):1543-50. PubMed ID: 22531721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.
    Liu F; Luo L; Liu Z; Wu S; Zhang W; Li Q; Peng Y; Wei Y; Li B
    Mol Carcinog; 2020 Nov; 59(11):1243-1255. PubMed ID: 32869896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
    J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shear stress-mediated changes in the expression of complement regulatory protein CD59 on human endothelial progenitor cells by ECM-integrinα
    Cui X; Zhang X; Bu H; Liu N; Li H; Guan X; Yan H; Wang Y; Zhang H; Ding Y; Cheng M
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):416-421. PubMed ID: 28943429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation.
    Cernoch M; Hruba P; Kollar M; Mrazova P; Stranavova L; Lodererova A; Honsova E; Viklicky O
    Front Immunol; 2018; 9():2310. PubMed ID: 30356754
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of the 5'HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits.
    Taboit-Dameron F; Malassagne B; Viglietta C; Puissant C; Leroux-Coyau M; Chéreau C; Attal J; Weill B; Houdebine LM
    Transgenic Res; 1999 Jun; 8(3):223-35. PubMed ID: 10478492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in complement regulators and susceptibility to age-related macular degeneration.
    Cipriani V; Matharu BK; Khan JC; Shahid H; Stanton CM; Hayward C; Wright AF; Bunce C; Clayton DG; Moore AT; Yates JR
    Immunobiology; 2012 Feb; 217(2):158-61. PubMed ID: 22024702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into Xenotransplantation for Cartilage Repair: Porcine Multi-Genetically Modified Chondrocytes as a Promising Cell Source.
    Tritschler H; Fischer K; Seissler J; Fiedler J; Halbgebauer R; Huber-Lang M; Schnieke A; Brenner RE
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the cytokine polymorphisms in correlation to rejection and graft survival in renal allograft donors and recipients from a homogenous Saudi population.
    Gaafar A; Iqniebi A; Sheereen A; Eldali A; Turpeinen H; Adra C; Al Meshari K; Al Hussein K
    Transpl Immunol; 2014 Jan; 30(1):34-9. PubMed ID: 24316141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
    Li Y; Parks GD
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of donor TNFRSF6 (FAS) gene polymorphism with acute rejection in renal transplant patients: a case-control study.
    Cappellesso S; Valentin JF; Giraudeau B; Boulanger MD; Al-Najjar A; Büchler M; Halimi JM; Nivet H; Bardos P; Lebranchu Y; Watier H
    Nephrol Dial Transplant; 2004 Feb; 19(2):439-43. PubMed ID: 14736971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between TLR2, TLR4, and CD14 Gene Polymorphisms and Acute Rejection in Kidney Transplant.
    Abdolvahabi R; Sarrafnejad A; Nafar M; Jafari D; Razaghi E; Lessan-Pezashki M; Yekaninejad MS; Sharif-Paghaleh E; Amirzargar A
    Exp Clin Transplant; 2018 Feb; 16(1):31-37. PubMed ID: 28411360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India.
    Srivastava P; Singh A; Kesarwani P; Jaiswal PK; Singh V; Mittal RD
    Clin Transplant; 2012; 26(4):581-8. PubMed ID: 22251233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the IL17A and IL17F gene polymorphisms on the long-term kidney allograft function and return to dialysis after kidney transplantation.
    Romanowski M; Kłoda K; Osękowska B; Domański L; Pawlik A; Safranow K; Ciechanowski K
    Clin Transplant; 2015 Dec; 29(12):1187-94. PubMed ID: 26447633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.